| scholarly article | Q13442814 |
| P2093 | author name string | Shun Lu | |
| Xiang-Yun Ye | |||
| Yun-Hua Xu | |||
| Zhi-Wei Chen | |||
| Zi-Ming Li | |||
| Xiao-Min Niu | |||
| Sheng-Ping Shen | |||
| Qing-Quan Luo | |||
| Nai-Wang Tang | |||
| P2860 | cites work | Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients | Q21198841 |
| Global cancer statistics | Q22241238 | ||
| Molecular alterations of h-warts/LATS1 tumor suppressor in human soft tissue sarcoma | Q28207639 | ||
| Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers | Q28237942 | ||
| Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target | Q28271520 | ||
| HSP90 inhibitors for cancer therapy and overcoming drug resistance | Q28274601 | ||
| Induction of premature senescence by hsp90 inhibition in small cell lung cancer | Q28474354 | ||
| E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. | Q28972461 | ||
| Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1 | Q30417692 | ||
| 17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells | Q33688498 | ||
| Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer | Q33710107 | ||
| Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluation | Q34102029 | ||
| Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway. | Q34268075 | ||
| The heat shock protein 90 inhibitor 17-AAG suppresses growth and induces apoptosis in human cholangiocarcinoma cells | Q34407501 | ||
| Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors | Q35064987 | ||
| Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins. | Q35636555 | ||
| Hypermethylation of the large tumor suppressor genes in Japanese lung cancer | Q36216645 | ||
| Apoptotic pathways and therapy resistance in human malignancies | Q36226739 | ||
| Secreted heat shock protein 90α (HSP90α) induces nuclear factor-κB-mediated TCF12 protein expression to down-regulate E-cadherin and to enhance colorectal cancer cell migration and invasion. | Q36724951 | ||
| Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma | Q36898402 | ||
| Expression of Transforming Growth Factor β1 and E-Cadherin Proteins in Pulmonary Adenocarcinoma: Its Significance in Tumor Progression | Q37011129 | ||
| The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals | Q37105079 | ||
| Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice | Q37316361 | ||
| LATS tumor suppressor: A new governor of cellular homeostasis | Q37799215 | ||
| The Hippo pathway in biological control and cancer development | Q37800053 | ||
| Heat shock proteins: a potential anticancer target | Q37903364 | ||
| Regulators of mammalian Hippo pathway in cancer | Q38017501 | ||
| Expression of Yes-associated protein in gastric adenocarcinoma and inhibitory effects of its knockdown on gastric cancer cell proliferation and metastasis | Q39261184 | ||
| 17-Allylamino-17-demethoxygeldanamycin and ritonavir inhibit renal cancer growth by inhibiting the expression of heat shock factor-1. | Q39370346 | ||
| Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance. | Q39429490 | ||
| Cell-cell junctions: α-catenin and E-cadherin help fence in Yap1. | Q39444842 | ||
| Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells | Q39464528 | ||
| Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. | Q40278675 | ||
| Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors | Q40611434 | ||
| The role of the hippo pathway in melanocytes and melanoma | Q40748577 | ||
| LATS1 tumor suppressor regulates G2/M transition and apoptosis | Q40750103 | ||
| Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma. | Q53235591 | ||
| Molecular alterations of E-cadherin and beta-catenin in brain metastases. | Q54394542 | ||
| A breakdown of the Hippo pathway in gastric cancer. | Q54557654 | ||
| P433 | issue | 3 | |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 651-663 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | 17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway | |
| P478 | volume | 19 |
| Q92981987 | Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model |
| Q38695460 | Effects of 17-allylamino-17-demethoxygeldanamycin on the induction of apoptosis and cell cycle arrest in HCT-116 cells |
| Q92454757 | Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC) |
| Q52682024 | Inhibition of Lats1/p-YAP1 pathway mitigates neuronal apoptosis and neurological deficits in a rat model of traumatic brain injury. |
| Q37085989 | Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling |
| Q60908274 | The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer |
| Q47230489 | YAP Is Decreased in Preeclampsia and Regulates Invasion and Apoptosis of HTR-8/SVneo |
| Q97540643 | Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer |
Search more.